Tag Archives: business

A Crash Course in SaaS

Image via Wikipedia Our magazine is called Pharmaceutical Executive—indicating a focus on the c-suite. But we know many of our readers aren’t executives (yet), and may not have quite the same in-depth knowledge as their bosses. So, for those who hear the term “SaaS” bandied about in conversations and fake their way through discussions about it [...]
Posted in Strategy | Also tagged , , , , , , | Leave a comment

BIO Convention: Potemkin Pavilions and the Power of NICE

Image by Getty Images via Daylife Last week’s annual meeting of BIO in Chicago once again proved illustrative in showcasing the high profile that governments now plays as the biotech sector’s chief advocate. While private venture capitalists confined themselves to the margins of the meeting, the Convention hall was bursting at the seams with host [...]
Posted in Biotech | Also tagged , , , , , , | Leave a comment

Merck Shows Off Bevy of New Drugs

Image by Chemical Heritage Foundation via Flickr While Merck’s net profits might be a little low in the wake of the Schering-Plough merger, it’s pipeline—and future sales—are far from bleak. According to a new report from analyst firm Deutsche Bank, Merck has no less than 18 drugs in Phase III development, with three slated for launch within [...]
Posted in R&D, Strategy | Also tagged , , , , , | Leave a comment

Webcast: SaaS or On-premise CRM—It’s Your Choice… Not Your Vendor’s

Tuesday, April 13, 2010 at 11:00 AM ET; 8:00 AM PT; 16:00 GMT As the life sciences industry continues to grow in complexity, its commercial model is changing too. The traditional ’single message to many’ approach to delivering your product information has been re-focused to building and maintaining relationships to achieve lasting share of mind. Given [...]
Posted in Webcast | Also tagged , , , , , , | Leave a comment

Making Sense of US Health Reform: Some Points for the Perplexed

The March 21 passage by Congress of the Patient Protection and Affordable Care Act provides at long last a rough blueprint for driving future commercial opportunities in the second-biggest industry sector of the world’s largest economy. With over 2,400 pages of text and a phase-in timetable that extends to 2019, it is prudent to invoke [...]
Posted in Op-Ed | Also tagged , , , , , , | 3 Comments